Dynamic Technology Lab Private Ltd Purchases Shares of 22,380 Option Care Health, Inc. (NASDAQ:OPCH)

Dynamic Technology Lab Private Ltd acquired a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 22,380 shares of the company's stock, valued at approximately $701,000.

Other institutional investors also recently modified their holdings of the company. UMB Bank n.a. increased its holdings in Option Care Health by 937.5% during the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company's stock valued at $26,000 after purchasing an additional 750 shares in the last quarter. GAMMA Investing LLC increased its stake in shares of Option Care Health by 110.6% in the third quarter. GAMMA Investing LLC now owns 897 shares of the company's stock valued at $28,000 after buying an additional 471 shares in the last quarter. Whittier Trust Co. of Nevada Inc. raised its holdings in shares of Option Care Health by 3,362.8% in the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company's stock valued at $47,000 after buying an additional 1,446 shares during the last quarter. International Assets Investment Management LLC raised its holdings in shares of Option Care Health by 3,029.7% in the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company's stock valued at $91,000 after buying an additional 2,757 shares during the last quarter. Finally, Blue Trust Inc. lifted its position in Option Care Health by 14.8% during the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company's stock worth $81,000 after buying an additional 377 shares in the last quarter. Institutional investors own 98.05% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the stock. JMP Securities boosted their target price on shares of Option Care Health from $36.00 to $37.00 and gave the stock a "market outperform" rating in a research note on Monday, September 30th. Truist Financial dropped their price objective on shares of Option Care Health from $41.00 to $34.00 and set a "buy" rating for the company in a research report on Friday, November 1st. The Goldman Sachs Group lowered Option Care Health from a "buy" rating to a "neutral" rating and decreased their price objective for the company from $38.00 to $27.00 in a research report on Monday, November 4th. Bank of America downgraded Option Care Health from a "buy" rating to a "neutral" rating and dropped their target price for the stock from $43.00 to $29.00 in a research report on Wednesday, October 30th. Finally, Barrington Research cut their price target on Option Care Health from $40.00 to $32.00 and set an "outperform" rating on the stock in a research note on Thursday, October 31st. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $30.83.

Option Care Health Trading Up 0.2 %

Shares of Option Care Health stock traded up $0.04 on Friday, hitting $23.80. 792,365 shares of the company's stock traded hands, compared to its average volume of 1,549,915. The firm's 50-day moving average price is $26.84 and its two-hundred day moving average price is $28.89. The stock has a market capitalization of $4.05 billion, a PE ratio of 20.00, a price-to-earnings-growth ratio of 2.46 and a beta of 1.32. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $34.63.

Insider Transactions at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of Option Care Health stock in a transaction on Friday, November 8th. The shares were purchased at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the acquisition, the director now owns 326,334 shares in the company, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 0.64% of the company's stock.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.